FDA approves BIMZELX for PsA, nr-axSpA, and AS; ACR launches self-management toolkit for rheumatic diseases; research links abdominal fat to chronic pain; osteoporosis rates decline in RA patients; FDA approves EBGLYSS for moderate-to-severe eczema; coffee consumption may lower heart disease and diabetes risk.